We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,725 hedge funds and large institutions have $233B invested in Johnson & Johnson in 2019 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 1,041 increasing their positions, 1,352 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less funds holding

Funds holding: 2,7562,725 (-31)

4.6% less ownership

Funds ownership: 72.98%68.38% (-4.6%)

7% less capital invested

Capital invested by funds: $252B → $233B (-$18.5B)

11% less call options, than puts

Call options by funds: $1.71B | Put options by funds: $1.91B

11% less first-time investments, than exits

New positions opened: 91 | Existing positions closed: 102

23% less repeat investments, than reductions

Existing positions increased: 1,041 | Existing positions reduced: 1,352

24% less funds holding in top 10

Funds holding in top 10: 639485 (-154)

Holders
2,725
Holders Change
-31
Holders Change %
-1.12%
% of All Funds
59.75%
Holding in Top 10
485
Holding in Top 10 Change
-154
Holding in Top 10 Change %
-24.1%
% of All Funds
10.63%
New
91
Increased
1,041
Reduced
1,352
Closed
102
Calls
$1.71B
Puts
$1.91B
Net Calls
-$203M
Net Calls Change
+$4.99M
Name Holding Trade Value Shares
Change
Change in
Stake
FBC
1101
Fairfield, Bush & Co
Connecticut
$5.25M -$32.9K -250 -0.6%
BWM
1102
Buckley Wealth Management
Nevada
$5.25M -$402K -3,051 -7%
CAM
1103
Costello Asset Management
Pennsylvania
$5.25M -$165K -1,252 -3%
APP
1104
Avantax Planning Partners
Iowa
$5.25M +$431K +3,272 +9%
FCT
1105
Family Capital Trust
Massachusetts
$5.23M -$1.84K -14 -0%
MGIA
1106
Moneta Group Investment Advisors
Missouri
$5.22M -$2.81M -21,331 -35%
CVSCT
1107
C.V. Starr & Co Trust
New York
$5.17M
SFG
1108
Summit Financial Group
West Virginia
$5.15M -$1.58M -11,981 -23%
FANJ
1109
Financial Architects (New Jersey)
New Jersey
$5.15M -$233K -1,768 -4%
MCP
1110
Martin Capital Partners
Oregon
$5.14M +$157K +1,195 +3%
SSWM
1111
Smith Salley Wealth Management
North Carolina
$5.14M +$147K +1,114 +3%
NAMP
1112
NorthStar Asset Management (Pennsylvania)
Pennsylvania
$5.13M +$77.3K +587 +2%
TC
1113
TownSquare Capital
Utah
$5.12M +$291K +2,207 +6%
FA
1114
FDx Advisors
Illinois
$5.12M -$2.91M -22,119 -36%
SFSG
1115
Stearns Financial Services Group
North Carolina
$5.11M +$90.8K +689 +2%
QIM
1116
Quantitative Investment Management
Virginia
$5.1M -$41M -311,189 -89%
NC
1117
Northpointe Capital
Michigan
$5.1M -$329K -2,501 -6%
DSC
1118
Duncker Streett & Co
Missouri
$5.08M +$28.2K +214 +0.5%
BCM
1119
BTR Capital Management
California
$5.07M -$1.36M -10,355 -21%
GP
1120
Greenline Partners
New York
$5.07M +$339K +2,576 +7%
WIC
1121
Whitegate Investment Counselors
New Hampshire
$5.07M +$5.53K +42 +0.1%
NL
1122
NWAM LLC
Washington
$5.06M +$2.41M +18,289 +88%
NHC
1123
Nicholas Hoffman & Company
Georgia
$5.06M -$75.8K -575 -1%
JWM
1124
JGP Wealth Management
Oregon
$5.06M +$90K +683 +2%
SRC
1125
Shufro Rose & Co
New York
$5.06M -$78.3K -594 -1%

JNJ Hedge Fund Activity: Q3 2019 in Review

2,725 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2019, worth a combined $233B — down 7.4% from $252B a quarter earlier.

Sellers outnumbered buyers: 102 funds closed out of JNJ and 91 opened new positions — a net loss of 11 holders — while 1,352 trimmed existing stakes and 1,041 added.

The largest buyer was Wellington Management Group, adding an estimated $304M. The largest seller was Phocas Financial Corp, cutting an estimated $16.5B.

  • 2,725 institutional investors held Johnson & Johnson (JNJ) as of Q3 2019, down from 2,756 in Q2 2019.
  • Funds reported $233B of Johnson & Johnson stock for Q3 2019, down 7.4% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q3 2019 and 102 closed out, a net change of -11 holders.
  • The largest Johnson & Johnson buyer in Q3 2019 was Wellington Management Group, an estimated $304M added.
  • The largest Johnson & Johnson seller in Q3 2019 was Phocas Financial Corp, an estimated $16.5B sold.

Based on aggregated 13F filings for Q3 2019.